Selected biotech news
The health care technology group, Nycomed Amersham, has agreed to sell a 70 percent stake in its pharmaceuticals business for £275m to a new company backed by Nordic Capital, a venture capital group based in Norway. Nycomed aims to concentrate on more profitable hi-tech operations such as X-ray imaging agents...